Respiration; international review of thoracic diseases
-
The Medical Research Council and the Nocturnal Oxygen Therapy Trial studies clearly demonstrated that long-term oxygen therapy (LTOT) for more than 15 h/day improved mortality and morbidity in a well-defined group of patients with chronic obstructive pulmonary disease. There are no similar randomised control studies in patients with other hypoxaemic lung diseases such as pulmonary fibrosis and pneumoconiosis. The prescription of oxygen for other restrictive lung disorders is complicated by hypoventilation requiring mechanical support as well as oxygen and should be restricted to special centres. ⋯ FEV1 should be less than 1.5 litres, and there should be a less than 15% improvement in FEV1 after bronchodilators. All patients should be assessed by an experienced chest physician. Patients with a PaO2 between 7.3 and 8 kPa who have polycythaemia, right heart failure or pulmonary hypertension may gain benefit from LTOT but this is still to be clearly proven.(ABSTRACT TRUNCATED AT 250 WORDS)
-
We report a case of pulmonary tuberculosis with bilateral hilar lymphadenopathy. Open thoracic lymph nodes and lung biopsy revealed findings consistent with sarcoidosis. ⋯ Culture of the postoperative sputum grew Mycobacterium tuberculosis and antituberculous therapy resulted in a decrease in sizes of the lymphadenopathy. A review of the literature, with emphasis on the differential diagnosis between tuberculosis and sarcoidosis, is discussed.
-
Mucoid impaction of tracheobronchial tree is a common condition which may complicate tracheostomy. Here we describe a case of a 72-year-old man, status after tracheostomy, who presented to the hospital with an acute upper airways obstruction and respiratory arrest due to a tracheal cast. The cast was successfully dislodged by the Nd-Yag laser.
-
Comparative Study
Bronchoalveolar lavage: comparison of three commonly used procedures.
We have studied three different lavage procedures (100, 200 and 300 ml) in patients with pulmonary sarcoidosis (stage I). The effect of bronchoalveolar lavage (BAL) on cell yield, lavage fluid recovery, dwelling time, lavage-induced arterial oxygen desaturation and occurrence of side effects was analyzed. The patients did not differ significantly in prelavage lung function and blood gas parameters. ⋯ Cough was the most often reported side effect (9 patients); fever was observed in 6 patients, dyspnea in 4 (all undergoing large-volume lavage). Considering our results we do not think that it is justifiable to increase the volume of instilled fluid above 200 ml, because this may lead to serious side effects without increasing benefits. Using lower than 200 ml volumes decrease diagnostic yield although the risk of developing side effects is much lower.
-
We studied the performance of a portable pulse oximeter in 123 consecutive adult patients by spot-checking with a finger probe and by spectrophotometry of oxygen saturation on a simultaneous arterial blood sample. 88 patients were overtly hypoxemic (HbO2 less than 90%) and 26 showed severe hypoxemia (HbO2 36-70%). The differences between the two methods showed a skewed distribution with a positive tail due to the over-estimation of lower saturation values by the pulse oximeter. Overall, the 95% confidence interval for the median difference ranged from -0.6 to +0.5%. ⋯ Pulse oximetry can be recommended as a first assessment of the respiratory balance only if a cut-off value of HbO2 equal to 90% in nonsmoking, air-breathing subjects is acceptable. The finger probe implies a response delay of approximately 30 s, making the instrument rather insensitive to short hypoxemic transients. With a predictive value around 90%, the pulse oximeter may be a useful portable screening tool.